Search research articles
Contact Us
Filters
Showing results (41-50 of 208) with videos related to
Page
of 21
Sort By:
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research
|
December 20, 2012
γ-H2AX foci formation as a pharmacodynamic marker of DNA damage produced by DNA cross-linking agents: results from 2 phase I clinical trials of SJG-136 (SG2000)
Jenny Wu, Peter H Clingen, Victoria J Spanswick, et al.
Cancer Immunology Research
|
March 12, 2016
Myelodysplastic Syndrome Revealed by Systems Immunology in a Melanoma Patient Undergoing Anti-PD-1 Therapy
Allison R Greenplate, Douglas B Johnson, Mikael Roussel, et al.
Head & Neck
|
July 24, 2010
Insulin-like growth factor-1 receptor inhibitor, AMG-479, in cetuximab-refractory head and neck squamous cell carcinoma
Christine H Chung, Paula R Pohlmann, Mace L Rothenberg, et al.
British Journal of Cancer
|
July 30, 2019
Patterns of response with talimogene laherparepvec in combination with ipilimumab or ipilimumab alone in metastatic unresectable melanoma
Jason Chesney, Igor Puzanov, Frances Collichio, et al.
Journal of Translational Medicine
|
May 12, 2019
The great debate at "Melanoma Bridge 2018", Naples, December 1st, 2018
Paolo A Ascierto, Paolo Bruzzi, Alexander Eggermont, et al.
Case Reports in Oncology
|
April 24, 2019
Cardiac Toxicity Associated with Immune Checkpoint Inhibitors: Case Series and Review of the Literature
Nikhil Agrawal, Arjun Khunger, Pankit Vachhani, et al.
The Oncologist
|
May 25, 2012
Is renal thrombotic angiopathy an emerging problem in the treatment of ovarian cancer recurrences?
Maryann Kwa, Robert Baumgartner, Linda Shavit, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research
|
December 24, 2009
A phase I trial of bortezomib with temozolomide in patients with advanced melanoma: toxicities, antitumor effects, and modulation of therapeutic targets
Yingjun Su, Katayoun I Amiri, Linda W Horton, et al.
Cancer Immunology Research
|
February 5, 2015
Survivorship in Immune Therapy: Assessing Chronic Immune Toxicities, Health Outcomes, and Functional Status among Long-term Ipilimumab Survivors at a Single Referral Center
Douglas B Johnson, Debra L Friedman, Elizabeth Berry, et al.
Journal of Translational Medicine
|
April 8, 2021
The "Great Debate" at Immunotherapy Bridge 2020, December 3rd, 2020
Paolo A Ascierto, Joshua Brody, Lisa H Butterfield, et al.
Page
of 21
Search research articles
Search
Showing results (41-50 of 208) with videos related to
Sort By:
Page
of 21
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research
|
December 20, 2012
γ-H2AX foci formation as a pharmacodynamic marker of DNA damage produced by DNA cross-linking agents: results from 2 phase I clinical trials of SJG-136 (SG2000)
Jenny Wu, Peter H Clingen, Victoria J Spanswick, et al.
Cancer Immunology Research
|
March 12, 2016
Myelodysplastic Syndrome Revealed by Systems Immunology in a Melanoma Patient Undergoing Anti-PD-1 Therapy
Allison R Greenplate, Douglas B Johnson, Mikael Roussel, et al.
Head & Neck
|
July 24, 2010
Insulin-like growth factor-1 receptor inhibitor, AMG-479, in cetuximab-refractory head and neck squamous cell carcinoma
Christine H Chung, Paula R Pohlmann, Mace L Rothenberg, et al.
British Journal of Cancer
|
July 30, 2019
Patterns of response with talimogene laherparepvec in combination with ipilimumab or ipilimumab alone in metastatic unresectable melanoma
Jason Chesney, Igor Puzanov, Frances Collichio, et al.
Journal of Translational Medicine
|
May 12, 2019
The great debate at "Melanoma Bridge 2018", Naples, December 1st, 2018
Paolo A Ascierto, Paolo Bruzzi, Alexander Eggermont, et al.
Case Reports in Oncology
|
April 24, 2019
Cardiac Toxicity Associated with Immune Checkpoint Inhibitors: Case Series and Review of the Literature
Nikhil Agrawal, Arjun Khunger, Pankit Vachhani, et al.
The Oncologist
|
May 25, 2012
Is renal thrombotic angiopathy an emerging problem in the treatment of ovarian cancer recurrences?
Maryann Kwa, Robert Baumgartner, Linda Shavit, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research
|
December 24, 2009
A phase I trial of bortezomib with temozolomide in patients with advanced melanoma: toxicities, antitumor effects, and modulation of therapeutic targets
Yingjun Su, Katayoun I Amiri, Linda W Horton, et al.
Cancer Immunology Research
|
February 5, 2015
Survivorship in Immune Therapy: Assessing Chronic Immune Toxicities, Health Outcomes, and Functional Status among Long-term Ipilimumab Survivors at a Single Referral Center
Douglas B Johnson, Debra L Friedman, Elizabeth Berry, et al.
Journal of Translational Medicine
|
April 8, 2021
The "Great Debate" at Immunotherapy Bridge 2020, December 3rd, 2020
Paolo A Ascierto, Joshua Brody, Lisa H Butterfield, et al.
Page
of 21